chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives and rashes on both days of vaccination and for a few days later Painful arm and shoulder from day one, worsened and has yet to subside Asthma day 5-11 after first vaccine ?Covid arm? rash day  9-13 after first injection Very painful small joints and elbows ongoing Easily fatigued limbs  Discoloration of left hand from time to time. Sometimes whiter, sometimes purple, specially in cold weather Tingling that turns into burning sensation/feels like I?ve been stung by stinging nettles when cold on top of left hand after second injection, ongoing
Pt recvd vax & shot was painful & sore for 3 days; pt also exp diarrhea, nausea, severe stomach cramps, h/a, weakness, sweating, joint pain, hard chills, vomiting, back pain, neck pain, aches, t100-102 & sense of being ill; gastroenteritis
started with funny feeling. Then Left jaw pain. Followed by neck pain. Stiff neck within 2 hours. took Benadryl. Nausea with weakness. Vital signs taken by mother who is nurse. B/P 102/70 Pulse 76 Temp. 97.8 resp 24. Pain worsened in jaw and neck took 800 mg. Motrin and bedrest. Mother watching for changes in status. Not reported til now
Pain and soreness around shoulder muscle in the arm that received the Shingrix vaccine; progressively worsening full-fledged flu-like symptoms: fever of 102; chills; severe nausea; upset stomach; general malaise; entire body muscle aches; severe headache; pain around eye sockets, ears, and neck; inability to function normally.  Treatment: stayed in bed for 14 hours, took regular dosages of aspirin every 4 - 6 hours, drank water frequently.  It is currently 23 hours following the time of vaccine injection, and fever has gone down to 100; full-fledge flu-like symptoms remain.  I am convinced these side effects are the result of the Shingrix, as I have gotten a seasonal flu shot annually for over 10 years, always with little or no side effects.
The first dose I experienced no symptoms. Only had pain in arm.   The second dose I experienced chills, fever and allergic reaction at site of shot.
first dose given to patient under eighteen years old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (first dose given to patient under eighteen years old) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (first dose given to patient under eighteen years old). On 18-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (first dose given to patient under eighteen years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Fever, Diarrhea, pain at injection site Narrative: sx lasted 2 days then resolved.
Patient lost consciousness and fell from the table.  He hit his head lightly with his mom partially  catching him. After 15-30 sec he regained consciousness. 5 min later upon sitting up he passed out again for 5-10 seconds. He could not sit up for 30 min - 1 hour later without  getting dizzy and was transferred to the ER.
This spontaneous prospective pregnancy report as received from a pharmacist refers to a 38 year old female patient. On 07-MAR-2014 the pregnant patient was inadvertently received a dose of GARDASIL (lot #, expiration date and dose unspecified), intramuscular instead of TDAP. No adverse effect was reported. The patient became pregnant with last Menstrual Period (LMP) of 09-AUG-2013 and Estimated date of delivery (EDD) of 16-MAY-2014. Initial exposure to GARDASIL was at 30 weeks. The pregnancy outcome was outcome pending. Additional information has been requested.
Myalgia, Arthralgia, Fever, rigors, night sweats, chills Narrative:
Patient reported flu like symptoms after the vaccine but what we are noting is what happened on the night/morning of Monday 8/23.  Patient had a headache and fast heartrate.  She said she couldn't calm it down and was pacing the room.  Her heart was beating irradically.  Today she reports it to be better.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Additional Details: After Benadryl 25mg, patient was feeling okay to go home. Caregiver/daughter took her home. Counseled can take addditonal benadryl if local symptoms return.
I am not sure if this was related to the last vaccine booster or simply caught a virus a few weeks after the vaccination.  Sore throat, cough lasting several weeks, stuffy nose, congestion - symptoms about a month after the booster.  Seemed like Covid symptoms.  By the time I got to the doctor, I was recovering (about a week).
Shortness of breath, fast heart rate, chest pain, aches. BP 174/107 pulse 79 oxygen saturation 96% temp 98.8. BP on discharge 105/75 pulse 73.
Right arm redness started on 2/5/2021.  Treated with ice to site TID.    Mostly resolved at this time.
AFTER RECEIVING VACCINATION THE PATIENT BEGAN FEELING DIZZY, COULDN'T SEE WELL THROUGH HER RIGHT EYE, FELT CHILLS. SHE APPEARED PALE 25 MINUTES AFTER VACCINATION. WAS IN OBSERVATION FOR A WHILE UNTIL SHE BEGAN FEELING BETTER AND LESS PALE.
COVID arm, swelling/lump at injection site.  Slightly sore and about 1.5 inches across.
burning smell that has continued; couldn't open eyes; couldn't move; very sick; severe body aches; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (burning smell that has continued), EYE MOVEMENT DISORDER (couldn't open eyes), MOBILITY DECREASED (couldn't move), ILLNESS (very sick) and MYALGIA (severe body aches) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 vaccination: Pfizer (Received Pfizer for both doses of primary series. After the second dose of Pfizer patient experienced same adverse reactions as of Moderna but it was less intense) from 20-Mar-2021 to 10-Apr-2021. Past adverse reactions to the above products included Vaccination adverse reaction with Pfizer.    On 22-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced PAROSMIA (burning smell that has continued). October 2021, the patient experienced EYE MOVEMENT DISORDER (couldn't open eyes), MOBILITY DECREASED (couldn't move), ILLNESS (very sick), MYALGIA (severe body aches), HEADACHE (headache) and PYREXIA (fever). In October 2021, EYE MOVEMENT DISORDER (couldn't open eyes), MOBILITY DECREASED (couldn't move), ILLNESS (very sick), MYALGIA (severe body aches), HEADACHE (headache) and PYREXIA (fever) had resolved. At the time of the report, PAROSMIA (burning smell that has continued) had not resolved.            No concomitant medications were reported.  Treatment information was not provided. After 12 hours of Moderna booster dose patient became very sick with headache, fever, severe body aches, could not open her eyes and couldn't move. These symptoms lasted about 48 hours.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent conditions, medical history or allergy/drug reactions were reported. On 08-JUL-2015, the patient was vaccinated with an expired dose of (Oka/Merck) PROQUAD injection (lot # J006867, expiration date: 14-DEC-2014) (strength, dose and route unspecified). No concomitant medications were reported. No known adverse effect was reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information  was provided. Additional information has been requested.
decreased mobility of the injected arm; pain in his rotator cuff; arm soreness; This case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included gastric ulcer.   In November 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 5 days after receiving Shingrix, the patient experienced injected limb mobility decreased, arthralgia and pain in extremity. On an unknown date, the outcome of the injected limb mobility decreased, arthralgia and pain in extremity were not recovered/not resolved.   It was unknown if the reporter considered the injected limb mobility decreased, arthralgia and pain in extremity to be related to Shingrix.  Additional details were provided as follows: In late november 2020, the patient received Shingrix in the right arm. The patient reported that about 5 days later, he experienced arm soreness, pain in his rotator cuff, and decreased mobility of the injected arm. The reporter consented to follow up.
Monday evening - Extreme pain in the arm where the injection was given. Swollen (like a baseball) and very red. I realize it would be sore; however, the pain radiated down the arm to the hand and upwards into my neck. A fever of 100 so I took tylenol.  Headache throughout the night and by morning my whole body hurt to the point I could not get out of bed.  Tuesday - I got up to go to the bathroom with help and lost consciousness. When checked at that time, I had a fever of 102, nausea and vomiting. These symptoms took place all day. I continued taking Tylenol for the pain. Not much sleep due to pain.  Wednesday - Some of the pain in the arm subsided; however, the spine pain was extreme. I struggled walking the pain severe. Throughout the day I was feeling a little better. Thursday - still body pain but tolerable.
Patient woke at 2 AM on 1/30/13 with swelling beneath tongue, aching, low grade temp. She is feeling better this morning. She did not seek medical attention.
Information has been received from a physician concerning a 56 yr old male pt with a seasonal allergy who on 04/01/2002 was vaccinated IM with 0.5ml of pneumococcal vaccine 23 polyvalent (lot number 64057/0995L) in the left deltoid. In less than a 24 hr. period from vaccination, the pt was noted to have red streaks going into the left armpit. The pt also had swollen lymph gland in the left armpit. The pt had no complaints of pain or fever. Unspecified medical attention was sought. The reporter requested a lot check on pneumococcal vaccine 23 polyvalent (lot number 640577/0995L). She also reported that the results of the lot check be forwarded to the office. The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
This spontaneous report as received from a physician refers to a 91 year old male patient with dementia and no drug reactions or allergies. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, strength, site and route of administration not reported). No concomitant therapies reported. On 20-AUG-2013 the patient was seen by the physician for a rash which a dose of had developed, which was diagnosed as pemphigoid vulgaris. No lab diagnostics performed. The patient was treated with prednisone (manufacturer unknown). The outcome of pemphigoid vulgaris was unknown. The relatedness between ZOSTAVAX and adverse event was not reported. The patient sought medical attention via office visit. Additional information has been requested.
diarrhea; jitteriness; night sweats but is not sure if she had those before or if it is the result of the vaccine; queasiness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FEELING JITTERY (jitteriness), NIGHT SWEATS (night sweats but is not sure if she had those before or if it is the result of the vaccine), NAUSEA (queasiness) and VACCINATION SITE PAIN (sore arm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced FEELING JITTERY (jitteriness), NIGHT SWEATS (night sweats but is not sure if she had those before or if it is the result of the vaccine), NAUSEA (queasiness) and VACCINATION SITE PAIN (sore arm). On 16-Apr-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea), FEELING JITTERY (jitteriness), NIGHT SWEATS (night sweats but is not sure if she had those before or if it is the result of the vaccine), NAUSEA (queasiness) and VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       There is no relevant treatment and concomitant medication provided.   Reporter did not allow further contact
Vaso Vagal Syncope. Felt warm and dizzy. Previous episodes after vaccines, blood draws, family events. No itching, hives, SOB, tongue or mouth swelling, palpitations. Supine on floor for several minutes and symptoms resolved. Walked around with no return of symptoms. Released to go home. Advised to seek treatment if symptoms return. Lungs CTAB, no hives. BP WNL after resting.
Received PREVNAR 13 vaccine on 12-9-16 had mild discomfort at the injection site. This improved over 2-3 days. On 12-15-16, patient noted his right deltoid region to be red and itchy.
Redness, swelling and itching-from top of shoulder to elbow-left arm.
knotted area at injection site (baseball sized) without redness or warmth; no streaking; no limitations in ROM once swelling improved. Hot shower and ice pack applied improved the swelling today.
The first vaccine was given on 5/24/21. We miss calculated the future date for the patient to return to receive the 2nd vaccine shot.  She was given her second shot on 6/14/21 instead of 6/21/21. We called the Moderna hotline and contacted the patient. Moderna did not have a serious concern. The patient did not report any side effects. This is a vaccine administration error only.
A patient with 7-month-old gestation/pregnant reported dizziness and pain in the pelvic area. At 2:30 90/50, 99%, 80P, 100 dxt, Doctor indicated rest and elevation of the lower extremities. After 15 min 110/80 BP, 98%, 83P, after several minutes he refers to feeling good and wants to go. The pulse is evaluated again and normal.
Started with normal sore arm, but soon became very sore-more than normal. Then started feeling swollen although not visibly red or swollen. Pain radiated intermittently down arm to hand. Over the next 3 days it felt like my underarm lymph nodes had swollen. Painful to keep my arm at my side, but also painful to raise my arm. Best to rest my arm at an angle on a surface. Overall, it took about 5 days for symptoms to improve and go away.
Localized reaction at injection site, erythema, fever 5/10/10 seen in office 5/11/10.  C/o pain at injection site.  No further vaccination per Dr.
Patient had drooping eyelids, occasional blurred vision, trouble swallowing, slurred speech, all over body was tired. Trouble breathing.
Lingering hip pain; Had styes in eyes; This is a spontaneous report from a contactable consumer. An adult non-pregnant female patient of unknown age received BNT162b2 (COMIRNATY; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, after taking COMIRNATY, the patient had styes in eyes and had lingering hip pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events had styes in eyes and lingering hip pain was resolved with lasting effects on an unknown date at the time of this report.   The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.
Frozen shoulder pain improved significantly. Less pain, more range of motion, better sleep because less nighttime pain.
Got both Moderna vaccine shots but recently tested for Covid positive again; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got both Moderna vaccine shots but recently tested for Covid positive again) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got both Moderna vaccine shots but recently tested for Covid positive again). At the time of the report, COVID-19 (Got both Moderna vaccine shots but recently tested for Covid positive again) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         Patient received both the Moderna vaccine shots but recently tested for COVID positive. It was reported that patient did not felt ill and was told to quarantine. No concomitant medications were reported. No treatment details were reported.
Given flu shot last month, but also given flu shot today. Patient and caregiver informed, but did not report any side effects.
p/vax pt was sitting in high chair & had a staring spell;child pulled out of high chair & body began to jerk & twitch;mom reports child T to 104;child rushed to ER;MD could find no signs of infect & no reason for having sz;
States swelling and pain on injection site area (half sized tennis ball) when she gets home from the vaccination. Consulted patient to take benadryl
Fever, 11pm 04/09/2021-10am 04/11/2021 (peaked at 101.5°) Headache 04/10/2021 Left arm pain 04/09/2021/04/11/2021 Nausea 04/09/2021-04/10/2021 Chills 04/10/2021 Treated with tylenol extra strength, took 2 times over the course of 10 hours
Lymphadenopathy (LAN) under left axilla + left breast mild; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 49 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 30Dec2020 (Lot number: EJ1685) at the age of 49 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "GERD" (unspecified if ongoing). Concomitant medication(s) included: PREVACID taken for gastrooesophageal reflux disease (ongoing). The following information was reported: LYMPHADENOPATHY (non-serious), outcome "not recovered", described as "Lymphadenopathy (LAN) under left axilla + left breast mild". Additional information: Event happened after the first dose. The patient had no prior vaccinations and no relevant tests.  No follow-up attempts are possible. No further information is expected.
Months later hospitalized for erratic BP and pulse. No history of heart or BP conditions. Normal (110/70) BP when laying down. Elevates immediately when standing (160/102 at highest). Resolved upon laying back down. Slight unspecific abnormality repeated on four EKGs. Normal bloodwork , stress test, X-rays and echo. Slight headache, fluttering racing heart with chest tightness, can hear and feel heartbeat throughout head and neck.  Is it possible this is vaccine related? (Had first and second shot in February)
major headache; no energy all day stayed in bed; all day throwing up; This is a spontaneous report from a contactable consumer (patient). A 71-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6200), via intramuscular route of administration in Deltoid Right on 18Feb2021 13:45 (age at vaccination of 71-years-old) as 2nd dose, single dose, for COVID-19 immunisation. The patient medical history was none; patient had no allergy. Concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EL8982), via intramuscular route of administration in Right Deltoid on 28Jan2021 13:41(age at vaccination of 71-years-old) for COVID-19 immunisation. Vaccination facility type was Doctors office, urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19. On 19Feb2021 at 04:00 the patient experienced major headache, no energy all day stayed in bed all day throwing up and vomiting. No treatment was given for the events. Since the vaccinations the patient has not been tested for COVID-19. The outcome of the all the events were resolved on an unspecified date.  Information on lot/batch number has been requested.  Follow-up (28May2021): This follow-up is being submitted to notify that the batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.  Follow-up (01Jun2021): New information received from a contactable reporter in response to the HCP letter sent for the patient which includes update on date, time, route of administration, anatomical site of injection, batch/lot number of the dose-1 and dose-2 COVID-19 vaccine. Vaccination facility type and address was also updated.  Follow-up attempts are completed. No further information is expected.
Itching at injection site, swelling and redness at injection site, extreme fatigue, muscle aches.   Itching and swelling at injection site is still ongoing 72 hours later, but other symptoms were gone within 24 hours.
Moderna COVID-19 Vaccine EUA  Patient states she began experiencing a Lupus flare the day following vaccination and continues with symptoms to present
On the evening of the day vaccine was given, pt started to feel bad with muscle aches, fever, pain, and back ache. Saw Dr. on 10/29/12 and given Rx's for pain and sleep meds. Problem persists at this time. Pt also has pain in same place she had shingles 30 mins ago back of shoulder radiating down arm.
PATIENT STATES: "I HAD MY VACCINE ON 2/23/2021 AND A SMALL BUMP APPEARED LATER ON.  ON 2/24/2021 I NOTICED THE BUMP BECAME LARGER LIKE WHEN I PLACE MY THUMB AND INDEX FINGER SPREAD OUT.  THE SITE IS PINK, WARM, ITCHES AND WHEN I RAISE MY ARM I CAN FEEL IT PULSATING.  I TOOK AN ADVIL AND LAID DOWN BUT IT DIDN'T HELP."